Table 4 Hazard ratio by quartiles of serum IGF-1 concentrations among ALS patients.
Hazard ratio (95%-CI) | |
---|---|
Crude (NDeceased = 243, NSurvived = 50)a | |
Bottom quartile (<80.8 ng/ml) | (ref.) 1.00 |
2nd quartile (80.8 -<99.9 ng/ml l) | 1.29 (0.90, 1.85) |
3rd quartile (99.9 -<121 ng/ml) | 1.17 (0.82, 1.66) |
Top quartile (≥121 ng/ml) | 0.97 (0.67, 1.40) |
p-value for trend | 0.78 |
Adjusted (NDeceased = 242, NSurvived = 50)b | |
Bottom quartile (<80.8 ng/ml) | (ref.) 1.00 |
2nd quartile (80.8 –<99.9 ng/ml) | 1.13 (0.78, 1.64) |
3rd quartile (99.9 –<121 ng/ml) | 1.22 (0.84, 1.76) |
Top quartile (≥121 ng/ml) | 0.90 (0.61, 1.31) |
p-value for trend | 0.66 |
75– < 90th percentile (121->140 ng/ml) | 0.87 (0.54, 1.40) |
90th percentile (≥140 ng/ml) | 0.93 (0.58, 1.48) |